Need Help With This Assignment?

Let Our Team of Professional Writers Write a PLAGIARISM-FREE Paper for You!

Discussion – Medication Access

Discussion – Medication Access

Medication access is a complex issue for patients with chronic conditions, specifically those who lack prescription coverage. This problem can lead to reduced overall quality of life, poor health results, and increased healthcare costs. In Upland, California, in order to address this, a comprehensive combined approach is required, which encompasses low-cost measures, financial assistance programs, community resources, and patient education initiatives. Therefore, this discussion aims to analyze and explore these strategies and critically evaluate the role of healthcare providers in determining prescription costs for individual patients.

Low-Cost Measures for Medication Access

One of the key strategies in the low-cost measures for medication access in patients with chronic conditions is the utilization of financial assistance programs. These programs are a lifeline for patients who cannot afford their medications. These programs are mostly sponsored by nonprofit organizations, pharmaceutical companies, or government agencies. One of the best examples is the patient assistance program (PAPs) which offers free or discounted medications to patients who are uninsured or lack insurance coverage and meet eligibility criteria. Some of the eligibility criteria include a certain income limit and proof of a lack of insurance coverage (Lawton & Brody, 2020). In Uplands, California, I have seen how PAPs can significantly lower or eliminate the cost of medications and cover a wide range of medications for patients who cannot afford their own medications.

Community resources

Community resources such as charitable organizations, community health centers, and local health clinics in Uplands, California, are crucial, as they also help patients with chronic conditions access their needed medications. These clinics provide free or discounted medications to eligible patients without medical insurance coverage. These clinics achieve this by receiving medication donations or forming partnerships with pharmaceutical companies to guarantee their patients receive all necessary treatments. Some of these charitable organizations may also help patients navigate the healthcare system barriers and find other resources necessary for medication access. The community resources in Upland, California, also help these patients access a variety of medical services and are more so for patients in underserved areas (Legido-Quigley et al., 2019).

Patient Education Initiatives

Comprehensive patient education is another strategy for improving medication access in my clinical area, Upland, California. Educating patients about their condition the importance of medication adherence, and various ways they can access affordable medications can empower them to take charge of their health and potentially reduce their healthcare costs. Some of the other components of their teaching include educating them on generic options and lifestyle modifications that can improve their overall health. This education is essential as it can improve patient health outcomes, reduce healthcare costs in the long run, and also involve them in their active role in their healthcare (Crabb et al., 2019). One of this strategy’s cons is that its success is fully dependent on patient understanding and engagement and requires time from healthcare providers to educate patients.

Role of Healthcare Providers in Determining Prescription Costs

Healthcare providers play a vital role in determining prescription costs for individual patients in Upland, California, where I practice. They are often the ones who choose the right medications to prescribe, and their choices can greatly have an impact on the cost of treatment (Fiscella et al., 2019). Healthcare providers can help in the reduction of prescription costs by applying the following key strategies: Prescribing generic medications when appropriate because they are relatively cheaper than the brand types and are equally effective (Desai & Gyawali, 2020), a careful consideration of the cost of helping the patients medications when choosing a treatment regimen to allow them to select affordable medications, and helping patients navigate financial challenges by providing information about financial assistance programs and other resources. Lastly, healthcare providers are involved in advocating for patients with insurance companies or pharmaceutical companies (Kang et al., 2019). However, they may face challenges in this area of prescription determination. They may lack full information about the cost of medications and have limited time to spend on cost-related issues. Furthermore, they must balance cost considerations with the need to provide the best possible care for their patients.

In conclusion, addressing the issue of medication access for patients with chronic conditions who lack prescription coverage requires a multifaceted approach. Financial assistance programs, community resources, and patient education initiatives can all play a role, and healthcare providers have a critical role to play in this process. In my clinical area, all these strategies are crucial for ensuring that patients get the medications required to manage their chronic conditions effectively and improve their overall quality of life.

References

Crabb, D. W., Im, G. Y., Szabo, G., Mellinger, J. L., & Lucey, M. R. (2019). Diagnosis and Treatment of Alcohol‐Related Liver Diseases: 2019 Practice Guidance from the American Association for the Study of Liver Diseases. Hepatology, 71(1). https://doi.org/10.1002/hep.30866

Desai, A., & Gyawali, B. (2020). Financial toxicity of cancer treatment: Moving the discussion from acknowledgement of the problem to identifying solutions. EClinicalMedicine, 100269. https://doi.org/10.1016/j.eclinm.2020.100269

Fiscella, K., Jineane Venci, Sanders, M., Lanigan, A., & Fortuna, R. (2019). A Practical Approach to Reducing Patients’ Prescription Costs. PubMed, 26(3), 5–9.

Kang, S.-Y., Bai, G., Karas, L., & Anderson, G. F. (2019). Pharmaceutical Industry Support of US Patient Advocacy Organizations: An International Context. American Journal of Public Health, 109(4), 559–561. https://doi.org/10.2105/ajph.2018.304946

Lawton, M. P., & Brody, E. M. (2020). Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living. The Gerontologist, 9(3 Part 1), 179–186. https://doi.org/10.1093/geront/9.3_part_1.179

Legido-Quigley, H., Naheed, A., de Silva, H. A., Jehan, I., Haldane, V., Cobb, B., Tavajoh, S., Chakma, N., Kasturiratne, A., Siddiqui, S., & Jafar, T. H. (2019). Patients’ experiences on accessing health care services for management of hypertension in rural Bangladesh, Pakistan and Sri Lanka: A qualitative study. PLOS ONE, 14(1), e0211100. https://doi.org/10.1371/journal.pone.0211100

ORDER A PLAGIARISM-FREE PAPER HERE

We’ll write everything from scratch

Question 


Discussion Prompt

Discussion - Medication Access

Discussion – Medication Access

Explore and analyze various strategies to address the issue of medication access for patients with chronic conditions who lack prescription coverage. Provide a brief assessment of low-cost measures, including financial assistance programs, community resources, and patient education initiatives in your specific clinical area. Critically evaluate the role of healthcare providers in determining prescription costs for individual patients.

Support your response with current research, citing both specific relevant community sources and scholarly references.